Patent ID: 11865170
Assignee: PAPIVAX BIOTECH INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 0:
1. A DNA vaccine, comprising:
a DNA construct comprising a fusion gene,
wherein the fusion gene includes an optimized human papillomavirus (HPV) subsequence encoding at least one HPV antigen, and
wherein the optimized HPV subsequence comprises one or more of:
an HPV-16 E6 expressing gene set forth in SEQ ID NO: 1,
an HPV-16 E7 expressing gene set forth in SEQ ID NO: 2,
an HPV-18 E6 expressing gene set forth in SEQ ID NO: 3, and
an HPV-18 E7 expressing gene set forth in SEQ ID NO: 4.